Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Retained Earnings: 2020-2024

Historic Retained Earnings for Molecular Partners Ag (MOLN) over the last 5 years, with Dec 2024 value amounting to -$280.0 million.

  • Molecular Partners Ag's Retained Earnings fell 37.70% to -$369,507 in Q3 2025 from the same period last year, while for Sep 2025 it was -$369,507, marking a year-over-year decrease of 37.70%. This contributed to the annual value of -$280.0 million for FY2024, which is 131024.48% down from last year.
  • Latest data reveals that Molecular Partners Ag reported Retained Earnings of -$280.0 million as of FY2024, which was down 131,024.48% from -$213,508 recorded in FY2023.
  • Molecular Partners Ag's 5-year Retained Earnings high stood at -$132,638 for FY2022, and its period low was -$280.0 million during FY2024.
  • Over the past 3 years, Molecular Partners Ag's median Retained Earnings value was -$213,508 (recorded in 2023), while the average stood at -$93.4 million.
  • Its Retained Earnings has fluctuated over the past 5 years, first surged by 99.87% in 2021, then slumped by 131,024.48% in 2024.
  • Yearly analysis of 5 years shows Molecular Partners Ag's Retained Earnings stood at -$215.9 million in 2020, then surged by 99.87% to -$272,156 in 2021, then soared by 51.26% to -$132,638 in 2022, then slumped by 60.97% to -$213,508 in 2023, then crashed by 131,024.48% to -$280.0 million in 2024.